American Association for Cancer Research

CIMM Election Results

Our thanks to Laurence Zitvogel, M.D., Ph.D., and Pamela S. Ohashi, Ph.D., F.R.S.C., for standing for election and to the membership of CIMM for participating in the election. Congratulations to Dr. Ohashi for having been elected as CIMM chairperson-elect. Dr. Ohashi will assume the office of chairperson-elect at the AACR Annual Meeting 2014, April 5-9, 2014, in San Diego, CA.

Pamela S. OhashiPamela S. Ohashi, Ph.D., F.R.S.C.
Director of Immune Therapy Program /
Senior Scientist
University of Toronto
Ontario Cancer Institute
Toronto, Ontario
Canada


Other positions currently held:

2013-present
Cross Appointment, Department of Medicine
University of Toronto
Canada

2009-present
Director, Immune Therapy Program
Ontario Cancer Institute
Canada

2007-present
Co-Director, Campbell Family Institute for Breast Cancer Research
Canada

2004-present
Senior Scientist, Campbell Family Institute for Breast Cancer Research, Canada

2001-present
Full Professor, University of Toronto, Department of Medical Biophysics and Immunology, Canada

Education:

1988
Ph.D.
Department of Immunology
University of Toronto
Toronto, Ontario, Canada


Awards:

2011
Investigator Award
Canadian Society for Immunology (CSI)

2010
Distinguished Lecturer
97th Annual Meeting of the American Association of Immunologists (AAI), Immunology 2010

2008-2015
Canada Research Chair
University of Toronto, Canada

2006
Fellow of the Royal Society of Canada

2004
Graduate Teaching Award for Excellence in Graduate Student Mentorship, University of Toronto, Faculty of Medicine, Canada

2003
Pharmingen Investigator Award
AAI

2001-2007
Canada Research Chair
University of Toronto, Canada

1998
William E. Rawls Prize
National Cancer Institute of Canada

1998-2001
MRC Scientist
Medical Research Council of Canada

1993-1998
MRC Scholarship
Medical Research Council of Canada

Committees:

2007-present Member, American Association for Cancer Research (AACR)

2008-present Member, Cancer Immunology (CIMM) Working Group of the AACR

2009-2011 Member, Cancer Immunology (CIMM) Steering Committee

2013-2014 Member, AAI Nominating Committee

2013 Member, Selection Committee, AACR-CRI Lloyd J. Old Award

2012-2013 Chair, AAI Nominating Committee

2012 Co-Chair, Scientific Program Committee, AACR Annual Meeting 2012

2011-2014 Member, Review Panel, Gairdner Medical Review

2010-2013 Chair, Awards Committee, AACR-CIMM Awards

2010-2011 Member, Steering Committee, CIHR: Inflammation in Chronic Disease Initiative

2010 Member, International Program Committee, International Congress of Immunology

2010 Advisor, Howard Hughes Medical Institute, Investigator Reviews

2010 Assessor, Australian National University's Research Assessment Exercise

2009 Member, Scientific Advisory Board, New Emerging Team in Clinical Autoimmunity (Head: Amit BAR-OR)

2009 Vice-Chair, Gordon Research Conference: Antigen Cross-Presentation

2007 Member, Program Committee, AACR Annual Meeting 2007

2003-2006 Member, Awards Committee, AAI

1999-2002 Member, Program Committee, AAI Council, AAI

Editorial Positions:

2012-present Senior Editor, Cancer Immunology Research, AACR

2012-present Associate Editor, Journal for Immunotherapy of Cancer

2001-present Transmitting Editor, International Immunology

2000-present Associate Editor, Cellular Immunology

1996-present Member, Advisory Editorial Board, Trends in Immunology

1996-present Associate Editor, Immunity

2008-2012 Executive Editor, European Journal of Immunology

Research Interests:
In the past decade, my lab has been focused on understanding the mechanisms that influence the decision between T-cell tolerance and activation and the impact of these mechanisms on autoimmunity and tumor immunity. Recent studies in my lab have established novel insights into critical molecular signaling pathways in dendritic cells that have an impact on the T-cell immunity in vivo. Work is currently underway to understand the regulatory mechanisms of this pathway. We are also focused on unraveling how the tissue or tumor microenvironment can have an impact on T-cell responses in various mouse and human models.

Proposed Goals:
It is a pleasure to serve as CIMM chairperson-elect, and I am happy to continue to support the AACR commitment in promoting cancer immunotherapy. I have been involved in several AACR initiatives: a past member of the AACR Cancer Immunology Steering Committee (2009-2011), co-chairperson of the AACR Scientific Program Committee (2011-2012), chair of the Awards Committee (2010-2013), and a member of the AACR-CRI Lloyd J. Old Award in Cancer Immunology Selection Committee (2013). I am also a senior editor on the AACR journal Cancer Immunology Research.

Cancer research continues to be an exciting field, and I am committed to maintaining the high profile of this discipline by providing input on establishing priorities for the scientific and educational goals of CIMM and the AACR Annual Meetings as well as the CIMM/AACR Special Conferences. It is also important to promote the AACR program, its membership and submission to Cancer Immunology Research. Additionally, I look forward to serving as a liaison with the AACR Board of Directors and provide a strong voice for the field of cancer immune therapy.